{"resourceType":"Observation","id":"047d7cfc-0884-536d-9714-dc0c94d7a06d","meta":{"versionId":"1","lastUpdated":"2022-05-24T15:35:12.967-04:00","source":"#yo6u2Jbfx6aofX9u","profile":["http://fhir.mimic.mit.edu/StructureDefinition/mimic-observation-micro-test"]},"identifier":[{"system":"http://fhir.mimic.mit.edu/identifier/observation-micro-test","value":"4357723-90116"}],"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"laboratory"}]}],"code":{"coding":[{"system":"http://fhir.mimic.mit.edu/CodeSystem/microbiology-test","code":"90116","display":"Chlamydia trachomatis, Nucleic Acid Probe, with Amplification"}]},"subject":{"reference":"Patient/a5d4cb17-db8d-574b-bd88-71473088fd9a"},"effectiveDateTime":"2198-11-16T10:25:00-05:00","valueString":"Negative for Chlamydia trachomatis by ___, APTIMA COMBO 2 Assay.  Validated for use on Urine Samples by the ___ Microbiology Laboratory. Performance characteristics on urine samples were found to be equivalent to those of FDA- approved TIGRIS APTIMA COMBO 2 and/or COBAS Amplicor methods.  ","specimen":{"reference":"Specimen/8cf82da9-5c1e-53af-8099-ea8cc970fda7"}}